Compare · BBH vs HCXY
BBH vs HCXY
Side-by-side comparison of VanEck Vectors Biotech ETF (BBH) and Hercules Capital, Inc. (HCXY): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BBH and HCXY operate in n/a (n/a), so they compete in similar markets.
- HCXY carries a market cap of $4.52B.
- Over the past year, BBH is up 20.7% and HCXY is down 0.5% - BBH leads by 21.3 points.
PerformanceBBH+20.73%HCXY-0.52%
2025-06-09+0.00%2026-06-05
Latest BBH
- VanEck Announces Year-End Distributions for VanEck Equity ETFs
- VanEck Announces Year-End Distributions for VanEck Equity ETFs
- VanEck Announces Year-End Distributions for VanEck Equity ETFs
- Mifepristone Abortion Pill Access in Limbo: Justice Department May Ask Supreme Court's Intervention
- Women's Reproductive Rights: US Court Preserves Access To Abortion Pill For Now, But With Tighter Rules
- New York and California Prepare For Potential Mifepristone Ban In Texas With Stockpiling Of Alternative Abortion Medications
- Attorney Generals of Over 20 States Sound Alarm Over Suspension Of Abortion Med Approval: "Devastating Risks" Ahead
- FDA Withdraws Lone Premature Birth Drug Makena Over Lack of Proven Benefits
- VanEck Launches Robotics ETF (IBOT)
- US Judge Weighs Nationwide Ban On Abortion Pills
Latest HCXY
- Hercules Capital Announces Date of 2026 Annual Meeting of Stockholders
- Hercules Capital Reports First Quarter 2026 Financial Results
- Hercules Capital Enters Next Phase of Growth with Expanded Leadership Team
- Hercules Capital Declares a Total Cash Distribution of $0.47 per Share for the First Quarter 2026
- Hercules Capital Announces Date for Release of First Quarter 2026 Financial Results and Conference Call
- Hercules Capital Sets New Record with All-Time High New Debt and Equity Commitments
- Hercules Capital Receives a BBB (high) Affirmed Investment Grade Corporate and Credit Rating from Morningstar DBRS
- Hercules Capital Named 2025 Americas BDC Manager of the Year by Private Debt Investor
- Hercules Capital Reports Fourth Quarter and Full-Year 2025 Financial Results
- Hercules Capital Closes Institutional Notes Offering of $300.0 Million 5.350% Unsecured Notes due 2029